New Redipor Broth Kit for operator aseptic broth transfer testing

24 Jun 2019

Kit provides all the key elements required to carry out an operator aseptic broth transfer test.

Cherwell Laboratories, specialists in products for process validation and environmental monitoring, will be introducing a new Redipor Broth Kit at the Aseptic Preparation and Dispensing Medicines (APDM) Training Course, 8-12 July. At the Leeds Trinity University located course and exhibition, Cherwell will be exhibiting a selection of its prepared media, including its brand new Redipor Universal Operator Broth Transfer Kit, and microbial air samplers.

New Redipor Broth Kit for operator aseptic broth transfer testing
Cherwell’s new Redipor Universal Operator Broth Transfer Kit.

The new Redipor Universal Operator Broth Transfer Kit provides all the key elements required to carry out an operator aseptic broth transfer test, making it very relevant to delegates attending the APDM course. This test is a standard assessment for operators engaged in the aseptic processing of medicines prior to undertaking aseptic preparation activities, as well as for routine operator monitoring.

The kit comprises a 50 mL Tryptic Soy Broth (TSB) injection vial; three empty 30 mL sterile injection vials; a 100 mL TSB broth bag and one 10 mL TSB ampoule. The EVA infusion bag included is particularly appropriate to TPN compounding. All components are supplied by Cherwell Laboratories in a purpose-made corrugated plastic box, for ease of use.

Andrew Barrow, Sales Manager, Cherwell Laboratories, who will be attending the event commented: “For some years we have been supplying many different presentations of broth for media fill simulations, including our customers’ own bespoke containers. This year we have introduced the Redipor Operator Broth Transfer Kit as a standard kit which can be easily ordered from us ‘off the shelf’, as requested by the NHS.”

Read More

Related news

Eisai collaborates with University of Dundee on cancer drug discovery

Eisai collaborates with University of Dundee on cancer drug discovery

10 Jul 2019

It is hoped that research into PROTACs will lead to new drug discoveries for proteins present in cancer, which are difficult to treat with conventional small molecule inhibitors.

Read more 
Onyx Scientific makes strategic investment in commercial API licence

Onyx Scientific makes strategic investment in commercial API licence

10 Jul 2019

Investment fills the growing gap in the market for manufacturers that have the niche capabilities to deliver small-scale commercial API projects.

Read more 
I Holland to share the science behind tool maintenance

I Holland to share the science behind tool maintenance

9 Jul 2019

Proper maintenance - rather than replacement - of compression tooling will improve profitability.

Read more 
Catalent extends global commercial spray drying capabilities in Europe

Catalent extends global commercial spray drying capabilities in Europe

9 Jul 2019

Company's customers to have immediate access to Niro PSD2 and PSD4 spray driers, which are supported by dedicated clean area facilities for both solvent and aqueous processing of potent or non-potent drug formulations.

Read more 
Operations commence at Wasdell Group’s EU headquarters

Operations commence at Wasdell Group’s EU headquarters

8 Jul 2019

The new facility houses 11 bespoke production suites and temperature controlled high-way warehouses increases Wasdell’s capacity in clinical and commercial packaging, distribution & logistics and QP services.

Read more 
Porvair Sciences launches first Drosophila ChIP kits

Porvair Sciences launches first Drosophila ChIP kits

4 Jul 2019

Offers a single optimised Chromatrap kit with unique buffers and components for Drosophila chromatin extraction and ChIP.

Read more 
Boehringer Ingelheim expands NASH R&D pipeline with new first-in-class compound

Boehringer Ingelheim expands NASH R&D pipeline with new first-in-class compound

3 Jul 2019

Yuhan Corporation to receive up to USD 870 million in upfront and success-based development and commercialization milestones, excluding royalties.

Read more 
Fresh data on protein interactions in Alzheimer’s disease

Fresh data on protein interactions in Alzheimer’s disease

2 Jul 2019

Demonstrates the unique ability of diffusional sizing to assess protein binding in-solution and for difficult-to-study systems.

Read more 
Fujifilm Irvine Scientific to open new cell culture media manufacturing site in Europe

Fujifilm Irvine Scientific to open new cell culture media manufacturing site in Europe

2 Jul 2019

The space will support cGMP manufacturing of animal component-free, dry powder media, liquid media, and downstream bioprocessing liquids.

Read more 
Novartis bolsters ophthalmic portfolio with acquisition of Xiidra

Novartis bolsters ophthalmic portfolio with acquisition of Xiidra

1 Jul 2019

Xiidra 5% is the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease.

Read more